Articles related to MEDICAL ETHICS

In the latest examination of DSM-5-TR, it’s revealed that nearly 60% of its panel members received payments from the pharmaceutical industry, highlighting the pervasive nature of financial conflicts in shaping psychiatric standards.

In correctional healthcare, respecting patient autonomy remains paramount, even when faced with court orders. This article highlights the importance of assessing patient capacity and making informed decisions in these challenging settings.

In the evolving landscape of AI in medicine, physicians grapple with the dual promises and challenges of ChatGPT. Privacy concerns, accuracy debates, and the potential to revolutionize patient care – discover the nuanced perspectives shaping the future of healthcare.

The study’s findings suggest that industry payments to oncologists could potentially influence treatment decisions, leading to the prescription of nonrecommended or low-value treatments. This raises important questions about the potential impacts of these payments on patient care.

The “revolving door” phenomenon, exemplified by the transition of Doran Fink from the FDA to Moderna, raises critical questions about public trust and regulatory integrity. As healthcare professionals, understanding these dynamics can inform our perspectives on regulatory processes and pharmaceutical industry relationships.

The study underscores the potential influence of pharmaceutical industry payments on the delivery of non-recommended or low value interventions in cancer treatment. It highlights the need for increased transparency and scrutiny in the financial relationships between physicians and the industry.